LysX2 is a Mycobacterium tuberculosis membrane protein with an extracytoplasmic MprF-like domain

Francesca Boldrin1, Laura Cioetto Mazzabò1, Marie-Antoinette Lanéelle2

  • 1Department of Molecular Medicine, University of Padua, Padua, Italy.

BMC Microbiology
|April 2, 2022
PubMed
Abstract

Insights

A novel enzyme, LysX2, enhances bacterial defense by altering cell surface charge, increasing resistance to antimicrobial peptides and acidic conditions. This finding is crucial for understanding pathogen survival strategies.

Area of Science:

  • Microbiology
  • Biochemistry
  • Pathogen Defense Mechanisms

Background:

  • Aminoacyl-phosphatidylglycerol (aaPG) synthases are bacterial enzymes crucial for pathogen defense.
  • These enzymes modify membrane phospholipids, conferring resistance to antimicrobial peptides and acidic environments.
  • Mycobacterium tuberculosis (Mtb) utilizes enzymes like MprF and LysX for these functions.

Purpose of the Study:

  • To characterize Rv1619 (LysX2) from Mtb as a potential new aaPG synthase.
  • To investigate the unique extracytoplasmic localization of LysX2's catalytic domain.
  • To assess the functional role of LysX2 in bacterial resistance and survival.

Main Methods:

  • Bioinformatic, genetic, and bacteriological analyses were employed.
  • Genetic fusions to bacterial reporter proteins (PhoA, LacZ) confirmed membrane topology.
  • Expression studies in Mycobacterium smegmatis assessed functional impacts.

Main Results:

  • LysX2 exhibits a unique extracytoplasmic membrane topology, unlike homologous enzymes.
  • Expression of LysX2 enhanced resistance to antimicrobial peptides and acidic stress.
  • LysX2 significantly reduced negative surface charge on bacteria in acidic conditions.

Conclusions:

  • LysX2 represents a novel class of MprF-like proteins with extracytoplasmic activity.
  • The enzyme's extracytoplasmic catalytic domain is key to reducing bacterial surface negative charge.
  • LysX2 likely contributes to the survival of pathogenic mycobacteria.